Carolyn A. Buser

Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma

Wing‐Kin Sung, Hancheng Zheng, Shuyu Li et al. · Nature Genetics · 2012 · 999 citations

Life Sciences, Molecular Biology, Molecular Genetics +16

Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models.

Robert B. Lobell, CharlesA. Omer, Marc Abrams et al. · PubMed · 2001 · 239 citations

Medicine, Oncology, Pharmacology +16

MK-1775, a Novel Wee1 Kinase Inhibitor, Radiosensitizes p53-Defective Human Tumor Cells

Kathleen A. Bridges, Hiroshi Hirai, Carolyn A. Buser et al. · Clinical Cancer Research · 2011 · 234 citations · Full text

Medicine, Cell Biology, Oncology +15

Amino-terminal basic residues of Src mediate membrane binding through electrostatic interaction with acidic phospholipids.

C T Sigal, Wenjun Zhou, Carolyn A. Buser et al. · Proceedings of the National Academy of Sciences · 1994 · 232 citations

Life Sciences, Biochemistry, Molecular Biology +17

Myristoylated Alanine-rich C Kinase Substrate (MARCKS) Produces Reversible Inhibition of Phospholipase C by Sequestering Phosphatidylinositol 4,5-Bisphosphate in Lateral Domains

Michael Gläser, Stephen Wanaski, Carolyn A. Buser et al. · Journal of Biological Chemistry · 1996 · 226 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17